110 related articles for article (PubMed ID: 3620938)
1. Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.
Palmer AM; Francis PT; Bowen DM; Benton JS; Neary D; Mann DM; Snowden JS
Brain Res; 1987 Jun; 414(2):365-75. PubMed ID: 3620938
[TBL] [Abstract][Full Text] [Related]
2. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
[TBL] [Abstract][Full Text] [Related]
3. Monoamine metabolism in senile dementia of Alzheimer type.
Cross AJ; Crow TJ; Johnson JA; Joseph MH; Perry EK; Perry RH; Blessed G; Tomlinson BE
J Neurol Sci; 1983; 60(3):383-92. PubMed ID: 6195313
[TBL] [Abstract][Full Text] [Related]
4. Changes in the brain catecholamines in patients with dementia of Alzheimer type.
Adolfsson R; Gottfries CG; Roos BE; Winblad B
Br J Psychiatry; 1979 Sep; 135():216-23. PubMed ID: 486847
[TBL] [Abstract][Full Text] [Related]
5. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
Vermeiren Y; Janssens J; Aerts T; Martin JJ; Sieben A; Van Dam D; De Deyn PP
J Alzheimers Dis; 2016 Jun; 53(3):1079-96. PubMed ID: 27314528
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical studies of Alzheimer's disease.
Palmer AM
Neurodegeneration; 1996 Dec; 5(4):381-91. PubMed ID: 9117551
[TBL] [Abstract][Full Text] [Related]
7. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A
Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.
Palmer AM; Francis PT; Benton JS; Sims NR; Mann DM; Neary D; Snowden JS; Bowen DM
J Neurochem; 1987 Jan; 48(1):8-15. PubMed ID: 2432177
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes of catecholamines and their metabolites content in the visual system of the rat.
Santiago M; Machado A; Cano J
Mech Ageing Dev; 1989 Jan; 47(1):77-84. PubMed ID: 2725071
[TBL] [Abstract][Full Text] [Related]
10. Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex.
Javoy-Agid F; Scatton B; Ruberg M; L'Heureux R; Cervera P; Raisman R; Maloteaux JM; Beck H; Agid Y
Neuroscience; 1989; 29(2):251-9. PubMed ID: 2471113
[TBL] [Abstract][Full Text] [Related]
11. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Reinikainen KJ; Soininen H; Riekkinen PJ
J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
Godridge H; Reynolds GP; Czudek C; Calcutt NA; Benton M
J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):775-8. PubMed ID: 2440994
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
Francis PT; Palmer AM; Sims NR; Bowen DM; Davison AN; Esiri MM; Neary D; Snowden JS; Wilcock GK
N Engl J Med; 1985 Jul; 313(1):7-11. PubMed ID: 2582256
[TBL] [Abstract][Full Text] [Related]
14. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
[TBL] [Abstract][Full Text] [Related]
15. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies.
Langlais PJ; Thal L; Hansen L; Galasko D; Alford M; Masliah E
Neurology; 1993 Oct; 43(10):1927-34. PubMed ID: 8105420
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin content and release measured in cerebral biopsies from demented patients.
Francis PT; Bowen DM; Lowe SL; Neary D; Mann DM; Snowden JS
J Neurol Sci; 1987 Mar; 78(1):1-16. PubMed ID: 3572446
[TBL] [Abstract][Full Text] [Related]
18. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
Guldberg HC; Yates CM
Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
[TBL] [Abstract][Full Text] [Related]
19. Distribution of catecholamines and serotonin in the rat cerebral cortex: absolute levels and relative proportions.
Reader TA
J Neural Transm; 1981; 50(1):13-27. PubMed ID: 7205246
[TBL] [Abstract][Full Text] [Related]
20. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.
Reinikainen KJ; Paljärvi L; Huuskonen M; Soininen H; Laakso M; Riekkinen PJ
J Neurol Sci; 1988 Mar; 84(1):101-16. PubMed ID: 2452858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
